Found 5 matching trials
Sarizotan in the Treatment of Neuroleptic-induced Tardive Dyskinesia
NATD is a troublesome and potentially irreversible side effect associated wit...
Location
Centre for Addiction and Mental Health
Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia
PHASE2The primary purpose of the study is to investigate the anti-dyskinetic effe...
Location
Multiple Locations
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
PHASE3The purpose of this study is to determine if Sarizotan HC1 1 mg b.i.d. (tak...
Location
Multiple Locations
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
PHASE3The purpose of this study is to test multiple doses of sarizotan to establi...
Location
Multiple Locations
Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
PHASE2This study evaluates the safety, tolerability and efficacy of Sarizotan in ...
Location
University of Alabama